RMD Earnings Date: Feb 4, 2027 (Estimated) — ResMed Inc.

NYSE · Healthcare · Medical Instruments & Supplies

Updated Oct 29, 2026

Price $252.83

Market Cap $36.5B

P/E 24.2

52W Range $179.75 – $275.42

Next Earnings Feb 4, 2027 · After close (est.)

When is RMD's next earnings date?

ResMed Inc. (RMD) is expected to report Q2 2027 earnings on Thursday, February 4, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $3.04 on revenue of $1.45B.

How did RMD do in its last earnings report?

In its most recent report on Oct 29, 2026 (Q1 2027), ResMed Inc. posted EPS of $2.91 versus the $2.69 estimate, a beat of 8.2%. Revenue was $1.41B against a $1.39B estimate.

How much does RMD stock move after earnings?

RMD beat EPS estimates in 8 of its last 8 reported quarters. Over the last 7 reports the stock moved an average of 4.7% (up or down) in the day after earnings.

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

🤖 AI Earnings Analysis

ResMed delivered a strong quarter for a respiratory-care leader: EPS of $2.91 beat consensus by $0.22 as revenue rose 8% year over year to $1.4 billion. Growth is solid, though the reported growth rates appear erroneous.

AI-generated summary — powered by BigEarnings.

Earnings History

Date	Period	EPS Est.	EPS Act.	Surprise	Revenue	Result	1D Δ	1W Δ	1M Δ
2026-10-29	Q1 2027	2.69	2.91	+8.18%	$1.41B	✅ Beat	—	—	—
2026-08-06	Q4 2026	2.89	2.95	+2.43%	$1.46B	✅ Beat	-5.06%	+1.57%	+2.58%
2026-04-30	Q3 2026	2.80	2.86	+2.14%	$1.43B	✅ Beat	-4.11%	-3.24%	-12.54%
2026-01-29	Q2 2026	2.71	2.81	+3.69%	$1.42B	✅ Beat	+0.27%	+3.66%	+0.14%
2025-10-30	Q1 2026	2.50	2.55	+2.00%	$1.34B	✅ Beat	-2.13%	-1.03%	-1.31%
2025-07-31	Q4 2025	2.47	2.55	+3.24%	$1.35B	✅ Beat	+2.67%	+3.03%	+1.16%
2025-04-23	Q3 2025	2.36	2.37	+0.42%	$1.29B	✅ Beat	+10.10%	+10.33%	+14.73%
2025-01-30	Q2 2025	2.31	2.43	+5.19%	$1.28B	✅ Beat	-8.33%	-7.94%	-9.32%